Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma
about
Lung Cancer Gene Signatures and Clinical PerspectivesOncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaPrognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseImplementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowThe relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalTumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinomaReevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysisTumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samplesNuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationVisceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classificationPrognostic relevance of TTF-1 expression in stage I adenocarcinoma.BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.Prognostic factors of patients with pathologic stage I lung adenocarcinoma.[Clinicopathological and prognostic significance of a panel of tumor biomarkers in lung adenocarcinoma: a tissue microarray study].
P2860
Q28387769-533AA636-8941-429B-B23D-C5B9F9A1AB47Q34073766-10BB4F68-21C1-4D49-B882-A9B561E85BD8Q34181641-E78161F8-8F4D-4F85-81BF-67AF1AE2477DQ34404229-DF77F488-7883-4E0D-BB1F-816E72FD9DB5Q34748124-ED0B1B18-CF16-4491-B5CC-3A08193C1102Q35151853-0C5FFED6-F2E2-4D48-B647-2D488D362A44Q35219157-9709FB9C-D491-4A2B-8B8C-4674C6266890Q35742165-1A10B415-572E-48EB-8070-309EFC76C825Q35845212-F2FBB4F6-9F74-4EBE-9563-C368E4E07232Q35940727-9382AB37-8BDE-495F-AF5F-D28D78D358AAQ35957585-9B64FD93-BA11-4B87-9BC4-14FD491C95D5Q36015463-0E9A4560-3CDF-4236-B69A-44E753E72000Q36261427-8FF56530-ABB9-42DF-B2A6-2D8032B71141Q36413817-41BEB15F-3801-47F8-8882-2E0B6D16067CQ37280912-02D113E4-27CC-4A68-881D-E8C8E511EF75Q37376521-F01BD7D4-1680-4101-923B-2AE362505D44Q39550621-A8EF3D45-AA94-49EB-9C0F-2982120B76EDQ40542208-0CFC62D4-9F2D-457C-AB44-D795729510FFQ42004921-F1EE4D3C-1146-4CD3-BA0C-4BE4EFC3E9A5Q47110752-4E1E55BA-A6F0-4C70-84B1-71BC841413DBQ47862701-55A54C5D-CE58-4524-AEFC-C0A08373AF6CQ54941144-F931EC5E-B451-4E2C-BAFC-0B0BFAEFFF9AQ55512522-8BC503E0-D293-483D-ACE6-97BCF882B266
P2860
Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Thyroid transcription factor-1 ...... th stage I lung adenocarcinoma
@en
type
label
Thyroid transcription factor-1 ...... th stage I lung adenocarcinoma
@en
prefLabel
Thyroid transcription factor-1 ...... th stage I lung adenocarcinoma
@en
P2093
P2860
P356
P1433
P1476
Thyroid transcription factor-1 ...... th stage I lung adenocarcinoma
@en
P2093
Akihiko Yoshizawa
Camelia S Sima
Inderpal S Sarkaria
Jun-Ichi Nitadori
Kyuichi Kadota
Prasad S Adusumilli
Valerie W Rusch
William D Travis
Xiaoyu Jia
P2860
P304
P356
10.1002/CNCR.27863
P407
P577
2012-10-23T00:00:00Z